Robert Malone MD- “Measles Outbreak”: Vaccine Skepticism, Media Manipulation and RFK’s fight for transparency 2m

Dr. Robert Malone addresses the recent measles outbreak in Texas, linking it to rising vaccine skepticism fueled by governmental overreach during the COVID-19 pandemic. He clarifies media misconceptions about deaths attributed to measles and critiques the narratives shaping public perception of vaccine safety. Malone discusses the technology behind the MMR vaccine, potential issues with live attenuated viruses, and the stifling effect of pharmaceutical industry practices on innovation. He also addresses the contentious link between vaccines and autism rates, advocating for informed consent and open dialogue. The conversation underscores the need for nuanced discourse in navigating public health challenges. Recorded 11.04.25 Connect with Dr Malone..... 𝕏                       x.com/RWMaloneMD WEBSITE           rwmalonemd.com/                          maloneinstitute.org/ SUBSTACK        malone.news

Connect with Hearts of Oak... 𝕏                         x.com/HeartsofOakUK WEBSITE            heartsofoak.org/ PODCASTS        heartsofoak.podbean.com/ SOCIAL MEDIA  heartsofoak.org/connect/ SHOP                  heartsofoak.org/shop/

*Special thanks to Bosch Fawstin for recording our intro/outro on this podcast.

Check out his art theboschfawstinstore.blogspot.com and follow him on 𝕏 x.com/TheBoschFawstin

 

Episode Transcript

Hearts of Oak: Hello, Hearts of Oak. Thanks so much for joining us once again. (00:24):
undefined

Hearts of Oak: And it is wonderful to have, (00:27):
undefined

Robert Malone: I think the first time. (00:28):
undefined

Hearts of Oak: This year again, Dr. Robert Malone. Robert, thank you so much for giving us your time today. (00:29):
undefined

Robert Malone: Thanks, Peter. I just back in from getting grain for the horses and got showered (00:37):
undefined

Robert Malone: and changed so we could do this broadcast to the UK. (00:42):
undefined

Hearts of Oak: You can do it on the back of a horse, Robert, anytime. Don't worry about that. (00:45):
undefined

Hearts of Oak: No problem with that. But obviously, there is your X handle on the screen. (00:51):
undefined

Hearts of Oak: And of course, Malone.news on Substack. And I encourage people not only to sign (00:58):
undefined

Hearts of Oak: up to Substack, but if you want to support Robert, you can do that by being a paid subscriber. (01:02):
undefined

Hearts of Oak: Only a couple of bucks a month. (01:07):
undefined

Hearts of Oak: Probably wouldn't even buy you a price off a coffee any longer stateside. (01:11):
undefined

Robert Malone: Certainly not a Starbucks. (01:16):
undefined

Hearts of Oak: No, not a Starbucks. Not a Starbucks. So yeah, I'd encourage you to do that. (01:17):
undefined

Hearts of Oak: And support the excellent work that robert is doing now (01:22):
undefined

Hearts of Oak: robert so much happening and we um i (01:26):
undefined

Hearts of Oak: sent you over some kind of talking points before and we (01:29):
undefined

Hearts of Oak: were chatting before we went live and (01:32):
undefined

Hearts of Oak: one of the the latest um news items on your sub stack is on was actually a trial (01:35):
undefined

Hearts of Oak: site news cross post on measles and there's a quote from it that says the stakes (01:43):
undefined

Hearts of Oak: don't get bigger in the world of health The measles outbreak flaring up in Texas. (01:50):
undefined

Hearts of Oak: Vaccine scepticism is on the rise since government overreach during the COVID-19 pandemic. (01:54):
undefined

Hearts of Oak: Since study after study shows the MR vaccine protects the population, (02:02):
undefined

Hearts of Oak: even when so-called breakthrough infections occur, they tend to be far more (02:08):
undefined

Hearts of Oak: mild, as one recent investigation demonstrates. (02:12):
undefined

Hearts of Oak: There's a lot of fear about this. I will maybe touch on some of the comments (02:17):
undefined

Hearts of Oak: from Bobby Kennedy talking about it. (02:24):
undefined

Hearts of Oak: But how do you see what is happening with this third death now of this measles outbreak in the U.S.? (02:27):
undefined

Robert Malone: So just to roll it up, what we have is two young girls, both of whom are asserted (02:39):
undefined

Robert Malone: to have been measles deaths, (02:48):
undefined

Robert Malone: but that's actually a false narrative. Both of them died of pneumonia. (02:50):
undefined

Robert Malone: One was a mycoplasma pneumonia, and the other one appears to be a community-acquired E. (02:54):
undefined

Robert Malone: Coli, multi-drug-resistant pneumonia, together in that case also with urosepsis, (03:00):
undefined

Robert Malone: which is infection of the urinary tract and kidneys. (03:05):
undefined

Robert Malone: So the third death that you're referring to is an elderly gentleman. (03:12):
undefined

Robert Malone: That's more measles associated but with other chronic health conditions. (03:17):
undefined

Robert Malone: So what we have is an example of an amplified narrative. A lot of this broke (03:25):
undefined

Robert Malone: inconveniently for the Trump administration. (03:33):
undefined

Robert Malone: Uh right before bobby kennedy (03:36):
undefined

Robert Malone: was confirmed and uh (03:40):
undefined

Robert Malone: this uh was originally (03:43):
undefined

Robert Malone: uh played in the media this outbreak in a mennonite community in texas so this (03:46):
undefined

Robert Malone: is uh if you're not familiar with mennonites it's kind of like uh the amish (03:53):
undefined

Robert Malone: in the united states you've encountered that peter But these are religious, (03:58):
undefined

Robert Malone: fundamentalist religious communities that do not endorse vaccination for whatever reason. (04:04):
undefined

Robert Malone: And it's kind of irrelevant to go down the rabbit hole of what their logic is, (04:13):
undefined

Robert Malone: you know, and whether it has merit or not. But that's their position, (04:18):
undefined

Robert Malone: is as a community, they don't accept vaccines. (04:23):
undefined

Robert Malone: And in particular, they don't vaccinate their children against measles, (04:27):
undefined

Robert Malone: mumps, and rubella, which is the vaccine that we have here in the United States, (04:31):
undefined

Robert Malone: one of the kind of key legacy vaccines produced by Merck, (04:35):
undefined

Robert Malone: also another version by GSK. (04:42):
undefined

Robert Malone: So, and this goes back to the kind of famous, almost immortal vaccinologist, (04:45):
undefined

Robert Malone: Maurice Hilleman, who worked at Merck. (04:55):
undefined

Robert Malone: And in the mumps component of the measles, mumps, (04:58):
undefined

Robert Malone: and rubella vaccine, it actually uses an attenuated virus that was derived from (05:02):
undefined

Robert Malone: the daughter of Hilleman called Gerald Lynn. (05:09):
undefined

Robert Malone: So that's the Gerald Lynn strain. So this is 60s technology. (05:15):
undefined

Robert Malone: And in the case of the measles component, what this is, is a live attenuated virus. (05:20):
undefined

Robert Malone: Now, that doesn't mean that it was gain-of-function engineered unless you think (05:29):
undefined

Robert Malone: that serial passage, which is kind of the virology equivalent of breeding of livestock. (05:34):
undefined

Robert Malone: Serial passage is the old-school method that goes back to the polio vaccine, (05:43):
undefined

Robert Malone: the live attenuated polio vaccine, where you repeatedly grow a virus, (05:51):
undefined

Robert Malone: a human pathogenic virus, on a cell line in culture, in tissue culture, in an incubator. (05:57):
undefined

Robert Malone: And those are very different conditions than the virus circulating in humans. (06:04):
undefined

Robert Malone: And so the virus will adapt to those conditions of growing in cell culture in an incubator. (06:12):
undefined

Robert Malone: And it will become more efficient at replicating, infecting and replicating (06:19):
undefined

Robert Malone: cell culture cells than replicating and infecting humans. (06:24):
undefined

Robert Malone: And as a consequence the virus will accumulate (06:30):
undefined

Robert Malone: these mutations through serial passage which is to (06:33):
undefined

Robert Malone: say you grow it once on a petri dish you take a sample put it on another petri (06:36):
undefined

Robert Malone: dish grow it again do it again and again and again and eventually you acquire (06:41):
undefined

Robert Malone: these uh modified viruses you could call it it's you know gain of function this (06:46):
undefined

Robert Malone: this illustrates kind of the complexity of the language of gain of function. (06:52):
undefined

Robert Malone: Is it gaining a function? Well, it's not specifically engineered to gain a function. (06:57):
undefined

Robert Malone: And back in the day when they were doing this, they didn't really know. (07:03):
undefined

Robert Malone: They didn't have sequencing. They didn't really know what the changes were. (07:06):
undefined

Robert Malone: They just knew that it was changed. (07:09):
undefined

Robert Malone: And they weren't purposely generating a specific type of change like increased (07:11):
undefined

Robert Malone: infectivity in humans like happened with the Wuhan Institute of Virology with SARS-CoV-2. (07:16):
undefined

Robert Malone: Okay, so calling this gain-of-function research, I think, is a little contrived. (07:21):
undefined

Robert Malone: But some out on the fringes are making that kind of statement. (07:26):
undefined

Robert Malone: But as a consequence, these live attenuated viruses created by serial passage (07:32):
undefined

Robert Malone: historically, including the live polio vaccine that is widely used throughout (07:37):
undefined

Robert Malone: the world, and yellow fever. (07:42):
undefined

Robert Malone: The yellow fever vaccine is another example. So all of these live attenuated (07:46):
undefined

Robert Malone: viruses produced by serial passage have the unfortunate tendency to occasionally acquire, (07:51):
undefined

Robert Malone: reacquire mutations that allow them to be more infectious in humans. (08:02):
undefined

Robert Malone: And so we call those revertents. (08:06):
undefined

Robert Malone: And the truth is that there are data now being published suggesting that the (08:11):
undefined

Robert Malone: majority of polio infections worldwide now, for instance, (08:19):
undefined

Robert Malone: seem to be vaccine-associated, which is a fancy way of saying, (08:23):
undefined

Robert Malone: kind of a pretty words way of saying, well, these are reverted, (08:27):
undefined

Robert Malone: live-attenuated mutants that now are infecting humans and causing, (08:32):
undefined

Robert Malone: in that case, polio disease. (08:37):
undefined

Robert Malone: And the same is true with the measles vaccine. (08:39):
undefined

Robert Malone: So that's just the unfortunate truth. (08:42):
undefined

Robert Malone: And this causes a lot of people to be hesitant. And then there's also various (08:46):
undefined

Robert Malone: side effects associated that are relatively rare. (08:50):
undefined

Robert Malone: But, uh, uh, the truth is, um, you know, this is kind of the, (08:54):
undefined

Robert Malone: you, you've, I don't know if you ever heard the metaphor in the land of the (09:00):
undefined

Robert Malone: blind, the one eyed man is king. (09:03):
undefined

Robert Malone: Uh, so, uh, in the land of not having much of anything to treat measles and (09:05):
undefined

Robert Malone: to prevent measles, a partially effective vaccine is better than nothing. (09:14):
undefined

Robert Malone: So jumping forward to the recent statement by bobby kennedy that has got uh the base of maha so. (09:19):
undefined

Robert Malone: I keep coming back to inflamed hemorrhoids as the metaphor uh i'm fired up let's (09:30):
undefined

Robert Malone: say uh is is bobby in a press release you know and you know saying that these (09:37):
undefined

Robert Malone: are bobby's words is a little contrived also. (09:43):
undefined

Robert Malone: This is an HHS press release citing Bobby as the source, which means that it's (09:46):
undefined

Robert Malone: been very carefully vetted and processed by the PR people at HHS. (09:52):
undefined

Robert Malone: Health and Human Services, the largest agency in the United States government. (09:57):
undefined

Robert Malone: Just to be clear, that's what Bobby is heading. It's actually bigger than the Department of Defense. (10:03):
undefined

Robert Malone: It is the major budget expenditure, HHS and Bobby is in charge of that. (10:09):
undefined

Robert Malone: Why he's down in the weeds visiting families and the Mennonite community in (10:15):
undefined

Robert Malone: West Texas, that's another topic. (10:21):
undefined

Robert Malone: But it's the consequence of this weaponized narrative. (10:24):
undefined

Robert Malone: So what we have is an outbreak in Mennonites. (10:29):
undefined

Robert Malone: That was picked up by the press because it fit the narrative that Bobby Kennedy is an anti-vaxxer. (10:35):
undefined

Robert Malone: And anti-vaxxer and Bobby equates to increased risk of death and severe infectious (10:43):
undefined

Robert Malone: disease in the general population. (10:52):
undefined

Robert Malone: That's the narrative that's being promoted. That was part of (10:54):
undefined

Robert Malone: what Senator Cassidy of Louisiana basically (10:57):
undefined

Robert Malone: held over Bobby's head in the confirmation process and is continuing to weaponize (11:01):
undefined

Robert Malone: that narrative in holding back confirmation on second tier appointments that (11:09):
undefined

Robert Malone: Bobby needs in order to be effective as the secretary of HHS. (11:17):
undefined

Robert Malone: So that's the political dynamics going on. (11:21):
undefined

Robert Malone: And so injected into that at the time of his confirmation was this unfortunate (11:24):
undefined

Robert Malone: outbreak in Mennonites in Texas. (11:29):
undefined

Robert Malone: And it's actually smaller, for instance, than the outbreak currently in Ottawa, Canada, of measles. (11:33):
undefined

Robert Malone: And it's much smaller than the measles cases reported in the European region by the WHO last year. (11:43):
undefined

Robert Malone: Nevertheless, the WHO has jumped on the bandwagon and declared that there is (11:53):
undefined

Robert Malone: a travel advisory to the United States because of this Mennonite community outbreak (11:59):
undefined

Robert Malone: for which there have been reported to be three deaths. (12:05):
undefined

Robert Malone: So I touched on those deaths and that the unfortunate truth is that the one (12:09):
undefined

Robert Malone: elderly gentleman and the elderly, (12:20):
undefined

Robert Malone: like with any of these viral pneumonias, (12:23):
undefined

Robert Malone: elderly are susceptible. (12:26):
undefined

Robert Malone: And one of the characteristics of the elderly that we need to just all get on (12:28):
undefined

Robert Malone: the same page on, is that as you age, (12:33):
undefined

Robert Malone: whether you acquired these pediatric (12:37):
undefined

Robert Malone: childhood infections historically and developed natural immunity, (12:41):
undefined

Robert Malone: which is more robust than vaccine-acquired immunity in almost all these cases, (12:46):
undefined

Robert Malone: but whether you acquired it naturally or through vaccines. (12:53):
undefined

Robert Malone: You develop a process called immunosenescence that's not well understood, (12:59):
undefined

Robert Malone: but the truth is that the elderly, and I'm getting there, become more susceptible. (13:03):
undefined

Robert Malone: They are immunologically become more weak as they age, and hence, (13:12):
undefined

Robert Malone: they are susceptible to, in particular, (13:21):
undefined

Robert Malone: upper respiratory infections and consequent, often bacterial pneumonia. (13:25):
undefined

Robert Malone: So one of the truths is that viral pneumonia often sets up a subsequent bacterial pneumonia. (13:31):
undefined

Robert Malone: So the whole logic of you don't treat a viral pneumonia with antibiotics because (13:37):
undefined

Robert Malone: otherwise you'll develop antibiotic-resistant bacteria, (13:43):
undefined

Robert Malone: well, that kind of falls apart in the case of upper respiratory viral pneumonia (13:46):
undefined

Robert Malone: with a susceptible individual because, and I get this all the time, (13:52):
undefined

Robert Malone: frankly, I get a community-acquired pneumonia from time to time. (13:56):
undefined

Robert Malone: And as soon as I sense the development of a bacterial pneumonia, (14:00):
undefined

Robert Malone: I immediately call my doc and say, hey, I need another round of, (14:05):
undefined

Robert Malone: and I'm not going to mention the antibiotics, but then they take care of that. (14:10):
undefined

Robert Malone: So this is kind of standard medical management practice. And in the elderly, (14:14):
undefined

Robert Malone: they do need to be carefully watched. (14:20):
undefined

Robert Malone: And in the young, they need to be carefully watched for the development of bacterial (14:24):
undefined

Robert Malone: pneumonia. and they have to be appropriately medically treated. (14:28):
undefined

Robert Malone: The most common cause of community-acquired pneumonia, what we call walking (14:34):
undefined

Robert Malone: pneumonia, is mycoplasma. (14:39):
undefined

Robert Malone: And in hospital, the most common cause is hospital-acquired multi-drug-resistant (14:42):
undefined

Robert Malone: bacteria, including E. coli. (14:48):
undefined

Robert Malone: Go ahead. (14:52):
undefined

Hearts of Oak: Now, I want to pick up on, kind of around this, another article that you wrote (14:53):
undefined

Hearts of Oak: just a day before probably two days ago as we record this and the drug repurposing (15:01):
undefined

Hearts of Oak: for measles disease treatment (15:07):
undefined

Hearts of Oak: and we kind of (15:10):
undefined

Hearts of Oak: heard the public heard about this during COVID and then those drugs that were (15:12):
undefined

Hearts of Oak: repurposed were not allowed to be used how does it work for measles and you (15:17):
undefined

Hearts of Oak: talked about the vaccine being 60s technology And I guess there's a, (15:23):
undefined

Hearts of Oak: there's a patent that a vaccine has, (15:28):
undefined

Hearts of Oak: and then it becomes a generic drug and therefore the company's not really money. (15:31):
undefined

Robert Malone: Yeah. So, so let's take that latter point and pick it apart a little bit, (15:36):
undefined

Robert Malone: because this is really important to understand the vaccine industry. (15:40):
undefined

Robert Malone: So because of the regulatory oversight and requirements in the United States, remember the FDA, (15:47):
undefined

Robert Malone: it's a little different from European Medicines Agency or TGA or the UK Ministry of Health. (16:01):
undefined

Robert Malone: In the United States, by statute, the FDA is not allowed to prescribe to a developer (16:09):
undefined

Robert Malone: what they need to do in order to get marketing authorizations. (16:18):
undefined

Robert Malone: Organizations, and the FDA regulates, (16:22):
undefined

Robert Malone: their authority flows from what is called the Commerce Clause in the Constitution, (16:26):
undefined

Robert Malone: which says that the federal government has the right to regulate interstate (16:32):
undefined

Robert Malone: commerce, and selling drugs across state lines is interstate commerce. (16:36):
undefined

Robert Malone: But the regulation of medical practice in the United States is controlled by (16:41):
undefined

Robert Malone: the states because it's not explicitly assigned to the federal government and (16:45):
undefined

Robert Malone: the Constitution. So that's the structure, just laying that out. (16:49):
undefined

Robert Malone: And then in the case of these products and vaccines in general. (16:53):
undefined

Robert Malone: What you have is a situation that, in addition to the intellectual property (17:01):
undefined

Robert Malone: patent issues, which expire in 20 years. (17:07):
undefined

Robert Malone: So just to put a context on that, these patents that cover, among other things, (17:11):
undefined

Robert Malone: the mRNA core technology for vaccines, have all expired. They're now public domain. (17:17):
undefined

Robert Malone: And the company that owned them during that time was never able, (17:25):
undefined

Robert Malone: they spent billions, but they were never able to reduce this to practice to a marketed product. (17:30):
undefined

Robert Malone: So basically, the company collapsed and the patents become generally available. (17:35):
undefined

Robert Malone: Now, in the case of these legacy vaccines from the 60s. (17:41):
undefined

Robert Malone: And there's a number of them. (17:47):
undefined

Robert Malone: Because in the 60s, basically had the second wave after the polio vaccine of, (17:49):
undefined

Robert Malone: it was really the kind of the golden age for vaccinology. (17:56):
undefined

Robert Malone: And all the easy targets of vaccine preventable disease got picked off really quick. (17:59):
undefined

Robert Malone: So there was a surge and Maurice Hilleman was at the front edge of that surge. (18:07):
undefined

Robert Malone: And a number of these vaccines that are now legacy vaccines were developed in that time period. (18:14):
undefined

Robert Malone: And what's important here is not just that they were developed and patented, (18:20):
undefined

Robert Malone: but that the manufacturing process was developed at that time. (18:29):
undefined

Robert Malone: And then the portfolio demonstrating safety and effectiveness. (18:33):
undefined

Robert Malone: Was generated. And that combination of manufacturing process and the data that was accepted by, (18:43):
undefined

Robert Malone: in our case, the FDA, becomes kind of a firewall to introduction of a new product into the market. (18:53):
undefined

Robert Malone: Because the new product, new vaccine product, has to show that it's either equally (19:04):
undefined

Robert Malone: effective and safer or equally safe and more effective in order to enter the market. (19:10):
undefined

Robert Malone: And to do so when you already have an existing vaccine that may be not perfect, (19:19):
undefined

Robert Malone: but we can argue about how effective, but it has some degree of effectiveness. (19:25):
undefined

Robert Malone: The consequence of that, to show that your new product is superior on either (19:31):
undefined

Robert Malone: safety or efficacy requires, it's just an artifact of statistics. (19:37):
undefined

Robert Malone: It requires a very, very large expensive trial. (19:42):
undefined

Robert Malone: Remember these vaccine trials, the average cost per patient is something like $8,000. (19:46):
undefined

Robert Malone: Depending on how sophisticated they are, it can go up to $20,000. (19:53):
undefined

Robert Malone: But for a routine vaccine trial. (19:56):
undefined

Robert Malone: We're talking about eight grand per. (20:00):
undefined

Robert Malone: And to demonstrate a non-inferiority or superiority outcome against an existing (20:02):
undefined

Robert Malone: product that's partially effective, you're up into the thousands of patients. (20:10):
undefined

Robert Malone: So you can do the math and it's real money. (20:14):
undefined

Robert Malone: So as a consequence, any new company wanting to enter that market has to say, (20:18):
undefined

Robert Malone: oh, we can come up with a new product and we can charge at a price point that'll (20:24):
undefined

Robert Malone: give us a 10x ROI on whatever that investment was, because otherwise they're not interested. (20:30):
undefined

Robert Malone: And so. (20:37):
undefined

Robert Malone: What this results in is an effective monopoly that is a cash cow in perpetuity. (20:40):
undefined

Robert Malone: Okay. And furthermore, it also means that if Merck was to reopen the regulatory (20:48):
undefined

Robert Malone: dossier for this historic vaccine, (20:57):
undefined

Robert Malone: then it's, you know, Katie, bar the door. (20:59):
undefined

Robert Malone: Anything goes. Okay, so if you were to go to the FDA, and this is just the way things work. (21:06):
undefined

Robert Malone: If you were to go to the FDA and say, hey, we got a new manufacturing process. (21:12):
undefined

Robert Malone: We want to develop that. And what ends up happening is you have this discussion (21:17):
undefined

Robert Malone: with the FDA. Well, is this a significant change in manufacturing? (21:21):
undefined

Robert Malone: If it is, then you can go forward and just make it a slight modification. (21:24):
undefined

Robert Malone: If it's a major change in the manufacturing process, then you've got to reopen (21:29):
undefined

Robert Malone: the whole portfolio. and then (21:34):
undefined

Robert Malone: you got to do the studies and then you open yourself up to competition. (21:37):
undefined

Robert Malone: The consequence is that you get locked. (21:40):
undefined

Robert Malone: These companies get locked into historic manufacturing processes that are absolutely (21:43):
undefined

Robert Malone: not aligned with modern GMP and GLP practices. (21:49):
undefined

Robert Malone: And furthermore, back in the day in the 60s, if you go back and look at those (21:56):
undefined

Robert Malone: old Maurice Hilleman clinical trials, they would not hold a candle to modern (22:00):
undefined

Robert Malone: clinical research standards. (22:06):
undefined

Robert Malone: They're small samples. They're not well-structured. They're not well-reported. (22:07):
undefined

Robert Malone: It was the norm back in the 60s, okay? (22:11):
undefined

Robert Malone: But the world progresses and regulatory standards progress until you get to (22:14):
undefined

Robert Malone: Operation Warp Speed and then you throw the whole thing in the garbage can. (22:22):
undefined

Robert Malone: But that's kind of the context. (22:24):
undefined

Robert Malone: And so these companies jealously guard. (22:30):
undefined

Robert Malone: These legacy vaccines because they are absolute cash cows. (22:35):
undefined

Robert Malone: Those aren't familiar with this financial industry lingo or business lingo. (22:40):
undefined

Robert Malone: Basically, they're products that you continue to milk for generations, (22:46):
undefined

Robert Malone: in this case, that you have very little expense associated with. (22:52):
undefined

Robert Malone: The manufacturing costs of these legacy vaccines is very low because it's based (22:56):
undefined

Robert Malone: on processes that have existed for, you know, middly, almost, (23:01):
undefined

Robert Malone: you know, we're pushing a hundred years now. Think about it. (23:06):
undefined

Robert Malone: You know, early sixties. So, and you've already built the plants, (23:10):
undefined

Robert Malone: you've already depreciated the plants, you know, what's not to like, (23:15):
undefined

Robert Malone: this is just revenue and it's almost pure profit. (23:19):
undefined

Robert Malone: So that's, that's the situation. And then as if that isn't good enough if you're Mr. (23:23):
undefined

Robert Malone: Merck or Mr. GSK or Mr. Pfizer. (23:29):
undefined

Robert Malone: Then you have the U.S. federal government after the first bird flu scare that (23:33):
undefined

Robert Malone: we had in which the vaccines that were deployed turned out to cause Guillain-Barre (23:43):
undefined

Robert Malone: syndrome and some deaths, (23:51):
undefined

Robert Malone: and the public became very alarmed about that. (23:53):
undefined

Robert Malone: They had to stop it, stop the things. (23:56):
undefined

Robert Malone: There started to be vaccine lawsuits and people were questioning vaccine safety. (23:58):
undefined

Robert Malone: And basically representatives of the vaccine industry came to Ronald Reagan (24:03):
undefined

Robert Malone: and scared the pants off of him and said, we're going to stop making vaccines unless you give, (24:09):
undefined

Robert Malone: here's another fancy word, indemnification. (24:15):
undefined

Robert Malone: Indemnification is for the secret decoder ring. (24:20):
undefined

Robert Malone: Indemnification means the federal government will absolve you of all liability (24:25):
undefined

Robert Malone: for any damages that are associated with your product and will set up a vaccine (24:30):
undefined

Robert Malone: court and a special fund. (24:37):
undefined

Robert Malone: And that will be used to compensate anybody that has vaccine damage. (24:40):
undefined

Robert Malone: But then it turns out that vaccine court is kind of stacked. (24:47):
undefined

Robert Malone: It's not very friendly. It's not very open to, you know, they act as if it's their own money. (24:50):
undefined

Robert Malone: And so it's really hard for people that are vaccine injured to get compensated. (24:57):
undefined

Robert Malone: You can appreciate how this is built up into a really a groundswell of anger (25:02):
undefined

Robert Malone: on the part of those relatively few people. (25:09):
undefined

Robert Malone: Being honest, that are either are truly vaccine damaged or their children are. (25:14):
undefined

Robert Malone: You know, relative to the entire population, they're a small subset. (25:20):
undefined

Robert Malone: But if you happen to be one of those mothers with a vaccine damaged child that (25:25):
undefined

Robert Malone: you have to take care of for the rest of their lives, it's everything to you. (25:29):
undefined

Robert Malone: And so we have this kind of growing groundswell of anger because of how things have been set up. (25:34):
undefined

Robert Malone: And the measles story plays into that because what we're having here in the (25:44):
undefined

Robert Malone: States is a, uh, you know, kind of a fundamental warring narrative conflict. (25:47):
undefined

Robert Malone: That's, that's what's happening here is we have two alternative narratives. (25:55):
undefined

Robert Malone: One has been actively suppressed. As I mentioned in the, (26:00):
undefined

Robert Malone: uh, in our time before this broadcast, there is actual congressional legislation (26:05):
undefined

Robert Malone: that explicitly states that information which can cause vaccine hesitancy, (26:10):
undefined

Robert Malone: I'm not quoting verbatim, (26:17):
undefined

Robert Malone: but I'm paraphrasing, (26:19):
undefined

Robert Malone: information which causes vaccine hesitancy causes individuals to become wary (26:21):
undefined

Robert Malone: or questioning whether or not they should accept these vaccines must be suppressed (26:26):
undefined

Robert Malone: in the interest of the greater good. (26:33):
undefined

Robert Malone: And so the logic is vaccines on (26:36):
undefined

Robert Malone: balance provide such benefits (26:41):
undefined

Robert Malone: to the general population that we have to withhold information about their potential (26:44):
undefined

Robert Malone: side effects from the general population or they won't take the product Because (26:50):
undefined

Robert Malone: the truth is that these vaccines are all of them. There is no perfect vaccine that I'm aware of. (26:54):
undefined

Robert Malone: They all have some percentage of effectiveness, which means that they also have (27:02):
undefined

Robert Malone: a percentage of unaffectiveness. (27:10):
undefined

Robert Malone: And so if you are, you know, so it's basically you take the jab and you roll (27:13):
undefined

Robert Malone: the dice. and you hope that you're in the group that, uh, is protected and doesn't (27:18):
undefined

Robert Malone: have one of the adverse events. (27:24):
undefined

Robert Malone: Or if you do, it's a minor adverse event like a swelling and redness or something or a mild fever. (27:26):
undefined

Robert Malone: Uh, but, but occasionally, uh, people get a major adverse event like facial (27:33):
undefined

Robert Malone: paralysis, Syskiy and Barry syndrome or, or other types of neurologic things (27:40):
undefined

Robert Malone: is one example. Uh, so that's. (27:45):
undefined

Robert Malone: We're in a battle of narratives in the United States, and really across the (27:50):
undefined

Robert Malone: Western world increasingly, (27:57):
undefined

Robert Malone: in which you have the narrative that vaccines are safe and effective, (27:59):
undefined

Robert Malone: shut up and don't question it, (28:04):
undefined

Robert Malone: versus, no, actually the data are more complicated like that than that. (28:06):
undefined

Robert Malone: They're not really that fully protective, depending on the vaccine. (28:13):
undefined

Robert Malone: And in some cases, they actually have, (28:19):
undefined

Robert Malone: you know, like I mentioned, the live polio vaccine, where we now have worldwide (28:24):
undefined

Robert Malone: data suggesting that there are more polio cases coming from vaccine revertent. (28:29):
undefined

Robert Malone: So people that have been vaccinated that then develop polio from the vaccine (28:35):
undefined

Robert Malone: than we have from actual wild polio. And we can now demonstrate that because (28:39):
undefined

Robert Malone: we have this cool new tech called PCR and sequencing. (28:45):
undefined

Robert Malone: So that's how we're getting to those data. And the same is true with measles, (28:50):
undefined

Robert Malone: that we have measles revertant infections. (28:54):
undefined

Robert Malone: And then we have periodic outbreaks. And measles is insanely infectious. (28:57):
undefined

Robert Malone: It is one of the most infectious viruses we know of. (29:03):
undefined

Robert Malone: Uh it has a if you're for those (29:06):
undefined

Robert Malone: that are in the weeds it has an r (29:09):
undefined

Robert Malone: naught which is a baseline coefficient of replication which (29:12):
undefined

Robert Malone: is to say if you're infected how many other people you infect on average of (29:15):
undefined

Robert Malone: something in the range of eight to ten um influenza is like one plus to two (29:21):
undefined

Robert Malone: plus uh and we think of influenza as highly infectious so that the the derivative (29:28):
undefined

Robert Malone: of that if you go through the math, (29:33):
undefined

Robert Malone: is that the measles vaccine to really be effective has to be deployed pretty much universally. (29:36):
undefined

Robert Malone: And even then, if you have an outbreak, you will get cases of measles. (29:44):
undefined

Robert Malone: Now, good news is that measles generally doesn't kill you, (29:50):
undefined

Robert Malone: which is why this amplified narrative of these three people dying is being so (29:53):
undefined

Robert Malone: promoted by those enforcing the narrative that vaccines are good, (29:59):
undefined

Robert Malone: they're safe and effective, and you ought to go out and get your jabs. (30:08):
undefined

Robert Malone: And so the assertion is, and this is amplified in, for instance, (30:12):
undefined

Robert Malone: two recent articles in the Journal of American Medical Association, (30:18):
undefined

Robert Malone: all of the American Medical Association structures, like, for instance, (30:20):
undefined

Robert Malone: the Pediatric Association, (30:28):
undefined

Robert Malone: American Medical Association, et cetera, all these specialty boards are all (30:30):
undefined

Robert Malone: on board with vaccinate, vaccinate, vaccinate, and don't worry about the risks. (30:34):
undefined

Robert Malone: In part because they take major amounts of money from pharma. (30:40):
undefined

Robert Malone: And that gets into the other part of this complexity is we have players that (30:45):
undefined

Robert Malone: are actively engaging with media through a variety of various means, (30:50):
undefined

Robert Malone: including engaging with the academic journals to promote this narrative that's (30:58):
undefined

Robert Malone: endorsed by the Congress, (31:03):
undefined

Robert Malone: U.S. Congress. (31:08):
undefined

Robert Malone: That vaccines are safe and effective and you shouldn't question it. (31:10):
undefined

Robert Malone: Take your jab and shut up. You know, again, I'm paraphrasing it. (31:13):
undefined

Hearts of Oak: Can I just pick up on that, Cliff? (31:17):
undefined

Hearts of Oak: Because RFK has, I've got a clip, (31:21):
undefined

Hearts of Oak: maybe just 30 seconds of him talking about that and this research and delving (31:24):
undefined

Hearts of Oak: into the safety of vaccines that certainly the public haven't heard of this (31:31):
undefined

Hearts of Oak: investigations before. (31:37):
undefined

Hearts of Oak: But can I just play this just 30-second clip of RFK, and then I want your thoughts (31:39):
undefined

Hearts of Oak: on where this is likely to go. (31:45):
undefined

Robert Malone: I've always said during my campaign and every part, every public statement I've (31:49):
undefined

Robert Malone: made, I'm not going to take people's vaccines away from them. (31:55):
undefined

Robert Malone: What I'm going to do is make sure that we have good science so that people can (31:59):
undefined

Robert Malone: make an informed choice. And we are doing that science today so that we know (32:03):
undefined

Robert Malone: the risks of that product, and we also know what the benefits are. (32:06):
undefined

Robert Malone: And right now, we don't know the risks of many of these products because they're not safety tested. (32:11):
undefined

Hearts of Oak: And I understand that position, but just to be clear, you are saying, (32:15):
undefined

Hearts of Oak: and we do on the federal level, and you personally do recommend that people (32:18):
undefined

Hearts of Oak: get the measles vaccine. (32:22):
undefined

Robert Malone: And when I say they're not safety tested, what I mean is they're not adequately. (32:24):
undefined

Robert Malone: Many of the vaccines are tested for only three or four days. (32:28):
undefined

Hearts of Oak: I love the way he sidesteps that. (32:34):
undefined

Robert Malone: Yeah, he absolutely did. I'm glad you picked up on that, Peter, (32:37):
undefined

Robert Malone: because that's crucial. (32:40):
undefined

Robert Malone: Bobby did not endorse measles vaccines in that statement and in others. (32:42):
undefined

Robert Malone: I mentioned that there was this HHS statement that was put out, (32:49):
undefined

Robert Malone: public statement in response to the media feed fest that's happening regarding (32:53):
undefined

Robert Malone: this West Texas outbreak, in which Bobby said, (33:01):
undefined

Robert Malone: that measles vaccination is the most effective way to slow or stop the spread of measles. (33:04):
undefined

Robert Malone: That is not the same as endorsing that everybody should go get the jab, (33:12):
undefined

Robert Malone: but it is a statement of fact. (33:16):
undefined

Robert Malone: That is absolutely a defensible position in terms of current data. (33:20):
undefined

Robert Malone: And what Bobby is saying here, and there's a whole lot of nuance behind this, (33:28):
undefined

Robert Malone: and uh current uh politics (33:34):
undefined

Robert Malone: in the united states so uh like in the uk we have a you have your yellow card (33:38):
undefined

Robert Malone: system we have a adverse event reporting system that is uh gently put suboptimal, (33:46):
undefined

Robert Malone: we actually have a number of them um some of them are more uh comprehensive (33:55):
undefined

Robert Malone: and particularly those associated with the military database, (34:01):
undefined

Robert Malone: and some of them are self-reporting systems that are notoriously under-reporting. (34:05):
undefined

Robert Malone: And historically, Congress had tasked and funded the CDC to develop a better (34:13):
undefined

Robert Malone: solution to tracking adverse events. (34:19):
undefined

Robert Malone: And the story I've heard repeatedly from government insiders at FDA and CDC, (34:23):
undefined

Robert Malone: is that the CDC succeeded in doing so. (34:31):
undefined

Robert Malone: And the data that came back from the initial runs of that in beta form, initial testing run. (34:36):
undefined

Robert Malone: Seemed to demonstrate that the vaccines had much more risk than had been publicly (34:46):
undefined

Robert Malone: acknowledged by the CDC. (34:53):
undefined

Robert Malone: And so, for whatever reason, I don't, I can't read minds, for whatever reason, (34:55):
undefined

Robert Malone: the CDC never deployed those improved systems, even though they were congressionally mandated to. (35:02):
undefined

Robert Malone: So you can make your own conclusions about what that means. (35:10):
undefined

Robert Malone: And in terms of the, you know, Remembering this is a UK broadcast, (35:13):
undefined

Robert Malone: what we saw with COVID is that the rest of the Western world pretty much defers (35:17):
undefined

Robert Malone: to the American regulatory establishment in terms of public health positions. (35:25):
undefined

Robert Malone: And we saw that with the politicization of the COVID narrative. (35:32):
undefined

Robert Malone: We saw that with the explicit agreements between U.S. and U.K. (35:37):
undefined

Robert Malone: To suppress information about (35:43):
undefined

Robert Malone: adverse events and risks associated with the genetic vaccine products. (35:45):
undefined

Robert Malone: We saw that with the Ehrlich Institute suppressing their own internal data in (35:50):
undefined

Robert Malone: response to political pressure from European Union and EMA and German politicians. (35:57):
undefined

Robert Malone: And all of it, and we saw that, I think it was the Norwegian report, (36:05):
undefined

Robert Malone: that the narratives associated with the genetic vaccine products were explicitly (36:11):
undefined

Robert Malone: reinforced through NATO channels. (36:19):
undefined

Robert Malone: So this business of, we can't say anything bad about vaccines because it will (36:22):
undefined

Robert Malone: cause vaccine hesitancy, which is all predicated on the thesis that these are safe and effective, (36:30):
undefined

Robert Malone: is now coming under scrutiny. (36:36):
undefined

Robert Malone: And it came to a head just, I think, last week, Peter Marks, Dr. (36:43):
undefined

Robert Malone: Peter Marks, MD, PhD, whose PhD ostensibly is in molecular biology, (36:52):
undefined

Robert Malone: but not virology, not immunology. (37:00):
undefined

Robert Malone: And it's in a branch of molecular biology having to do with receptor biology. (37:02):
undefined

Robert Malone: It's really more a cell biology thing. So he really doesn't understand molecular (37:08):
undefined

Robert Malone: virology, immunology, all those kinds of things. (37:13):
undefined

Robert Malone: But he kind of was elevated to the position of head of the Center for Biologics (37:15):
undefined

Robert Malone: Evaluation and Research, which is the branch of FDA responsible for vaccines. (37:24):
undefined

Robert Malone: And he was the godfather together with another kind of deep state player that (37:29):
undefined

Robert Malone: is very aligned with the military industrial biodefense complex. (37:35):
undefined

Robert Malone: Of Operation Warp Speed. And (37:42):
undefined

Robert Malone: Peter had been under pressure from (37:46):
undefined

Robert Malone: HHS and from Secretary Kennedy to allow outside review scrutiny of the FDA and (37:49):
undefined

Robert Malone: the CDC databases as they exist in their imperfect state concerning vaccine safety. (38:03):
undefined

Robert Malone: And he intentionally, by his own words in. (38:09):
undefined

Robert Malone: Recent interviews after he was let go, (38:14):
undefined

Robert Malone: he obstructed the ability of others within the government aligned with Secretary (38:18):
undefined

Robert Malone: Kennedy to access these databases and determine what they did or didn't show (38:26):
undefined

Robert Malone: in terms of vaccine safety. (38:32):
undefined

Robert Malone: So he was let go for that explicit reason. (38:35):
undefined

Robert Malone: And what we now have, and there was a recent statement that is not in that clip (38:39):
undefined

Robert Malone: from Secretary Kennedy, that they now have access to that database. (38:47):
undefined

Robert Malone: How a government official would block access to a database, (38:54):
undefined

Robert Malone: that implies that they were in some (38:58):
undefined

Robert Malone: way in control of passwords and other key information to allow a protected information (39:01):
undefined

Robert Malone: technology data to be accessed and were blocking other government officials (39:12):
undefined

Robert Malone: from getting access to that. (39:19):
undefined

Robert Malone: I don't see how that's within their purview, but it kind of illustrates the (39:21):
undefined

Robert Malone: parent bias that Peter Marks had. (39:26):
undefined

Robert Malone: And this is not, vaccines are not the only product that he's come under fire for. (39:29):
undefined

Robert Malone: He's approved multiple other products over the objections of his own FDA personnel. (39:35):
undefined

Robert Malone: Products that turn out to be less effective and safe than was originally purported. (39:42):
undefined

Robert Malone: So he's got this history of actively (39:49):
undefined

Robert Malone: advancing interests of the pharmaceutical industry over and above and essentially (39:53):
undefined

Robert Malone: circumventing the cautionary notes that his own expert personnel have raised (39:59):
undefined

Robert Malone: about the safety and effectiveness of those new products. (40:06):
undefined

Robert Malone: So he's let go. Bobby and his people are now diving into the database. (40:12):
undefined

Robert Malone: And Bobby recently said that within the next couple of months, I'm paraphrasing, (40:18):
undefined

Robert Malone: you can expect some major disclosures about what these FDA and CDC databases really demonstrate. (40:24):
undefined

Robert Malone: And that gets to his point that he made in the clip that you just played, (40:33):
undefined

Robert Malone: that his position, and this is highly nuanced, right, in order to get through (40:37):
undefined

Robert Malone: his Senate confirmation and Senator Cassidy, (40:44):
undefined

Robert Malone: who's a Republican, his objections. (40:47):
undefined

Robert Malone: Uh, et cetera. (40:50):
undefined

Robert Malone: Uh, he basically had to sell a little part of his soul, you know, (40:52):
undefined

Robert Malone: metaphorically, uh, and say that he wasn't going to just come right out and, uh, (40:57):
undefined

Robert Malone: ban the pediatric current pediatric schedule or any of these vaccines, (41:04):
undefined

Robert Malone: like a lot of the base wants the Naha base, (41:08):
undefined

Robert Malone: they they're mad as hell that he hasn't already banned the genetic vaccines (41:11):
undefined

Robert Malone: for COVID, and they're still being jabbed and recommended for infants, (41:15):
undefined

Robert Malone: which makes no sense at all. Absolutely true. (41:19):
undefined

Robert Malone: And I think that's the European position, is that those products don't make sense in infants. (41:23):
undefined

Robert Malone: We can argue about whether they make sense in certain at-risk populations, (41:30):
undefined

Robert Malone: like diabetics and people with inflammatory disorder and the elderly, (41:36):
undefined

Robert Malone: but in the case of infants and young children, there's no case to be made for these products. (41:40):
undefined

Robert Malone: Yet the United States government continues to insist that they should be administered. (41:46):
undefined

Robert Malone: So that's the dynamic that's going on. And this statement from Bobby that measles (41:51):
undefined

Robert Malone: vaccines are our best tool for slowing and stopping an outbreak. (41:58):
undefined

Robert Malone: That's not to say they're perfect, but as I said, in the land of the blind, (42:03):
undefined

Robert Malone: the one-eyed man is king. (42:08):
undefined

Robert Malone: In this case, measles vaccination is the one-eyed man. (42:09):
undefined

Robert Malone: So what it really emphasizes is we truly need better alternatives. (42:13):
undefined

Robert Malone: And this feeds into this Budesonide story that you mentioned that I also covered. (42:20):
undefined

Robert Malone: This is a frontline physician in West Texas that has been historically working (42:28):
undefined

Robert Malone: with this religious community to treat disease arising in this community of unvaccinated persons. (42:37):
undefined

Robert Malone: Now, measles generally is not lethal. (42:49):
undefined

Robert Malone: And historically, in the United States, back in the 60s, people would have measles (42:54):
undefined

Robert Malone: parties, just like they would have chickenpox parties, to get their children exposed to it. (42:58):
undefined

Robert Malone: Because as a childhood illness, it is relatively benign in most cases, (43:02):
undefined

Robert Malone: unless you had a preexisting condition. (43:10):
undefined

Robert Malone: And so this position is treating these. (43:13):
undefined

Robert Malone: And there's strong parallels, as you mentioned, to COVID, where it turns out (43:19):
undefined

Robert Malone: that unlike the Imperial College modeling false narrative of 3.4% case fatality rate, (43:24):
undefined

Robert Malone: a COVID case fatality rate, as demonstrated by Jay Bhattacharya, (43:31):
undefined

Robert Malone: who's now the director of NIH, has a case fatality rate that's just around what (43:37):
undefined

Robert Malone: a bad seasonal influenza outbreak is. (43:46):
undefined

Robert Malone: So, therefore, in the case of COVID, (43:50):
undefined

Robert Malone: drug treatments that operated at the margins, you know, were, (43:57):
undefined

Robert Malone: especially when administered early, (44:03):
undefined

Robert Malone: could cause more rapid recovery of something that really wasn't that bad of (44:05):
undefined

Robert Malone: an infection, is the truth. (44:12):
undefined

Robert Malone: Unless you were one of these special people, and keep you out of the hospital, (44:13):
undefined

Robert Malone: where if you were hospitalized in the United States, you were treated with a (44:17):
undefined

Robert Malone: rather toxic drug called remdesivir, (44:20):
undefined

Robert Malone: and then early on with ventilation that turns out to be totally counterproductive. (44:24):
undefined

Robert Malone: Uh, and, uh, so, um, because of misunderstandings by, uh, pulmonologists about, (44:31):
undefined

Robert Malone: uh, the nature of the disease, that this was a, basically a disease of blood coagulation, (44:39):
undefined

Robert Malone: not a disease in microvasculature compromise, not a disease of, uh. (44:45):
undefined

Robert Malone: Compromise of air exchange, uh, at the alveolus. (44:51):
undefined

Robert Malone: So they kind of misunderstood that this wasn't, you know, your usual viral infection, (44:55):
undefined

Robert Malone: but because the ACE2 receptor was acting through other pathways and they applied the, (45:02):
undefined

Robert Malone: you know, another metaphor, (45:09):
undefined

Robert Malone: if you give a three-year-old a hammer, everything becomes a nail. (45:11):
undefined

Robert Malone: So they applied the hammer that they knew of from other respiratory diseases, (45:14):
undefined

Robert Malone: and it made things worse and killed people. That's the ugly truth. (45:20):
undefined

Robert Malone: So in the case of measles, what this doc has determined is that a combination (45:25):
undefined

Robert Malone: of antibiotics, because you have to prepare. (45:31):
undefined

Robert Malone: Measles is suppressive, immunosuppressive, absolutely. (45:35):
undefined

Robert Malone: And pulmonary infection of measles, which is the common, one of the common sequelae, (45:40):
undefined

Robert Malone: sets you up for bacterial pneumonia, as I mentioned, or microplasmin. (45:46):
undefined

Robert Malone: And it's immunosuppressive. You know, it's damaging lung. (45:51):
undefined

Robert Malone: So that makes it easier to get colonized with these other adventitious agents. (45:55):
undefined

Robert Malone: And so this doc has found in his, (46:00):
undefined

Robert Malone: the kind of the crucible of treating all these children, that if he gives them (46:04):
undefined

Robert Malone: a aerosolized inhaled pulmonary, (46:13):
undefined

Robert Malone: you know, (46:18):
undefined

Robert Malone: a steroid compound, (46:21):
undefined

Robert Malone: eudesonite, that is used for other pulmonary inflammatory diseases, including asthma. (46:24):
undefined

Robert Malone: I mean, I've used an asthma inhaler with Budeson-9 myself. (46:31):
undefined

Robert Malone: Very available. And if you combine that with antibiotics, (46:35):
undefined

Robert Malone: you can really pop these kids out of, you can abbreviate their clinical course (46:39):
undefined

Robert Malone: so that they're not having, you know, days of distress, but rather maybe a day or even hours. (46:44):
undefined

Robert Malone: So it's not a cure, but it is greatly alleviating the secondary disease and (46:53):
undefined

Robert Malone: symptoms, the cycle that gets set up. (47:01):
undefined

Robert Malone: And this is very similar to the logic that was applied in COVID with these repurposed drugs, (47:04):
undefined

Robert Malone: that the FDA got its head totally wrapped around the idea that it has to be (47:11):
undefined

Robert Malone: an active antiviral in order to be effective. (47:16):
undefined

Robert Malone: And what they overlooked was that things that acted indirectly to reduce disease (47:20):
undefined

Robert Malone: severity were good enough. (47:26):
undefined

Robert Malone: Uh, and, uh, so, and it appears that ivermectin is one of those agents. (47:29):
undefined

Robert Malone: It appears that hydroxychloroquine is one of those agents, but, (47:35):
undefined

Robert Malone: uh, the FDA insisted that at the doses being administered, you couldn't demonstrate (47:39):
undefined

Robert Malone: a direct antiviral effect in cell culture. (47:45):
undefined

Robert Malone: Therefore it was all gibberish. And that, the sad truth of that is that's all (47:48):
undefined

Robert Malone: based on another narrative, another false narrative. (47:55):
undefined

Robert Malone: It's been overthrown recently. It has to do with the fundamentals of pharmacokinetics, (47:58):
undefined

Robert Malone: that's drug distribution. (48:03):
undefined

Robert Malone: And it's kind of old school thinking about how drugs work, but the FDA is just (48:06):
undefined

Robert Malone: locked in. This is the way things are. (48:14):
undefined

Robert Malone: There's a saying that the FDA and the CDC will only, they only change one death at a time. (48:16):
undefined

Robert Malone: And what they're referring to is death of They're bureaucrats. (48:22):
undefined

Robert Malone: They get locked into these positions and they won't move off of them. (48:26):
undefined

Robert Malone: So that's what we really have going on here is a major problem with large-scale group things. (48:31):
undefined

Robert Malone: Where the regulatory agencies and corporate media, in corporate media in particular, (48:41):
undefined

Robert Malone: don't really have a lot of depth in terms of understanding these nuances of medicine. (48:49):
undefined

Robert Malone: They've got their head wrapped around narratives that are outdated. (48:56):
undefined

Robert Malone: And what's happening if you kind of look, let's take the high road. (49:02):
undefined

Robert Malone: Go up to 40,000 feet and look down. What's going on here is Bobby is taking (49:09):
undefined

Robert Malone: the position in children's health defense and in Del Bigtree and the whole anti-vaxxers. (49:15):
undefined

Robert Malone: What they're really saying is, hey, guys, your data to support your thesis that (49:22):
undefined

Robert Malone: these things are all safe and effective is outdated. (49:27):
undefined

Robert Malone: And even worse we know that (49:30):
undefined

Robert Malone: you know you know this is like the uh um the uh statement uh i forget who the (49:33):
undefined

Robert Malone: attribution is uh um we know they're lying they know they're lying we know that (49:40):
undefined

Robert Malone: they know that they're lying we know that they know that we know that they're (49:46):
undefined

Robert Malone: lying and yet still they lie um some. (49:49):
undefined

Hearts of Oak: Told me it was solzhenitsyn but i don't actually know (49:52):
undefined

Robert Malone: If that's correct yeah precisely so It's attributed to Solzhenitsyn. (49:54):
undefined

Robert Malone: Thank you. I was having a senior moment there. (49:58):
undefined

Robert Malone: That's kind of what's going on here, is that because they're not just approved, (50:04):
undefined

Robert Malone: but legislatively mandated position, (50:14):
undefined

Robert Malone: that vaccine safety and effectiveness shall not be questioned. (50:18):
undefined

Robert Malone: There's this active suppression of discussion about what the data truly show. (50:24):
undefined

Robert Malone: And that kind of came to a head with peter marx um he was taking the he you (50:32):
undefined

Robert Malone: know think about it he was taking the official position which has the long-standing (50:39):
undefined

Robert Malone: position of the cdc and the fda that thou shalt not question even if the data shows otherwise. (50:44):
undefined

Robert Malone: And they show that that happened here in the UK, in EMA, European Union, (50:50):
undefined

Robert Malone: European Council, all wrapped around that same axle that you shouldn't question this. (50:57):
undefined

Robert Malone: And the derivative of that is that patients don't have true informed consent. (51:04):
undefined

Robert Malone: And it's all built around the structure of kind of top-down narrative control. (51:10):
undefined

Robert Malone: It's top-down central planning, because that's what modern public health has (51:26):
undefined

Robert Malone: come to, is the thesis that greatest good for the greatest number. (51:31):
undefined

Robert Malone: And you can't question our decision about what is the greatest, (51:40):
undefined

Robert Malone: good for the greatest number. (51:44):
undefined

Robert Malone: WHO is, this is like their, this ought to be their charter, right? (51:45):
undefined

Robert Malone: Which is fundamentally socialist, okay? And I know that socialism in the UK (51:49):
undefined

Robert Malone: versus socialism in the United States, there's a different political spectrum. (51:54):
undefined

Robert Malone: But calling it like I see it, (51:59):
undefined

Robert Malone: this is central planning socialist philosophy that these government agents know (52:03):
undefined

Robert Malone: best for you and basically facetiously shut up and take your medicine. (52:11):
undefined

Robert Malone: And that is breaking down now in the age of the Internet, in social media. (52:18):
undefined

Robert Malone: Uh it's it's becoming clear that that's increasingly non-defensible and so they're (52:25):
undefined

Robert Malone: having to resort to censorship and propaganda and everything else. (52:31):
undefined

Hearts of Oak: Can i can i just want to ask one and i i know 10 minutes is not enough to do (52:35):
undefined

Hearts of Oak: this justice but i just want to get your initial thoughts uh because i've never (52:41):
undefined

Hearts of Oak: actually sat and discussed this with anyone and that is the (52:44):
undefined

Hearts of Oak: concern about MMR and the links to autism. (52:50):
undefined

Hearts of Oak: And Bobby has talked about this and talked about the huge rise and said, (52:54):
undefined

Hearts of Oak: I think by the end of the year, we're going to find out. (53:00):
undefined

Hearts of Oak: And no one is actually in government has actually talked about looking into (53:03):
undefined

Hearts of Oak: this and finding out if there is a link to MMR. (53:08):
undefined

Hearts of Oak: And it's just accepted this is just something that has happened. (53:14):
undefined

Hearts of Oak: And it's an issue of not a rise in cases, but an issue of labeling cases. (53:17):
undefined

Hearts of Oak: And it's just an increase in labeling is an increase in rise. (53:25):
undefined

Hearts of Oak: What are your thoughts on that? It's a huge subject, I know, (53:28):
undefined

Hearts of Oak: but maybe sometime we can delve into this much deeper. (53:33):
undefined

Robert Malone: Let's unpack what you just put out, (53:39):
undefined

Robert Malone: is, uh, the counter narrative that, uh, the rise. (53:42):
undefined

Robert Malone: So the, the data are the official data are that, uh, autism has become extremely prevalent, uh, (53:49):
undefined

Robert Malone: particularly in the United States over the last, uh, you know, (54:00):
undefined

Robert Malone: whatever, how many decades you want to look, but, but, um, (54:04):
undefined

Robert Malone: so that those of the official data is that autism has risen to the point where (54:11):
undefined

Robert Malone: it's something like one in 50 or I'm not sure what the number is, but it's very high. (54:17):
undefined

Robert Malone: Uh, and as Bobby has said, for instance, on the Rogan interview that he did, (54:23):
undefined

Robert Malone: uh, when he was a child, uh, (54:28):
undefined

Robert Malone: you didn't see, uh, autistic, other autistic children and you don't see autistic (54:33):
undefined

Robert Malone: elders, uh, with these, uh, more in that. (54:40):
undefined

Robert Malone: So their autism is a spectrum of disease severity, but you, you, (54:46):
undefined

Robert Malone: you encounter in your daily life, (54:53):
undefined

Robert Malone: these people that are severely disabled in various ways and, you know, (54:56):
undefined

Robert Malone: largely non-functional uh from (55:02):
undefined

Robert Malone: a social productivity standpoint uh they (55:05):
undefined

Robert Malone: they are fairly routinely encountered uh and (55:10):
undefined

Robert Malone: yet they are almost exclusively in (55:14):
undefined

Robert Malone: younger age cohorts and if this if this was (55:19):
undefined

Robert Malone: a if if (55:22):
undefined

Robert Malone: the counter narrative that you just mentioned that uh this uh this official (55:25):
undefined

Robert Malone: rise in autism is just the consequence of a broadened definition of what clinical autism represents. (55:32):
undefined

Robert Malone: I'm rephrasing what Jesus said a moment ago. (55:43):
undefined

Robert Malone: So the thesis, the counter-narrative is that, oh, these additional autism cases (55:47):
undefined

Robert Malone: are just an artifact of how we're now defining autism, which is more broad than (55:51):
undefined

Robert Malone: it was previously defined. (55:57):
undefined

Robert Malone: If that was the case, then you would be seeing elders of my cohort that were (55:58):
undefined

Robert Malone: in this severe autistic spectrum. Now. (56:07):
undefined

Robert Malone: And then, so then, uh, consequence to Andy Wakefield and others, (56:13):
undefined

Robert Malone: there was injected this narrative that MMR is, uh, the, the bad actor in this, uh, rise. (56:18):
undefined

Robert Malone: Well, think about it. If that was the case and my age cohort, (56:28):
undefined

Robert Malone: I mean, I was, I was vaccinated for smallpox. (56:34):
undefined

Robert Malone: My age cohort, I'm, I'm of a certain age, uh, 65. So my age cohort received (56:38):
undefined

Robert Malone: all these vaccines, received these MMR vaccines, and yet we don't see severe autism in my age cohort. (56:44):
undefined

Robert Malone: Oh, that's a problem if you're bought into it's all about MMR. (56:50):
undefined

Robert Malone: I strongly suspect, (56:55):
undefined

Robert Malone: but just to, so that, that narrative that it's all about MMR was, uh, (56:59):
undefined

Robert Malone: injected into public discourse and, uh, it was very actively suppressed, (57:07):
undefined

Robert Malone: which triggered a subset of the population to, (57:15):
undefined

Robert Malone: um, you know, be oppositionally defiant. (57:21):
undefined

Robert Malone: Well, if you're suppressing it so actively, then there must be something there. (57:23):
undefined

Robert Malone: Where there's smoke, there's fire, right? (57:28):
undefined

Robert Malone: And so paradoxically, for one subset of the population, (57:30):
undefined

Robert Malone: the PSYOP, or psychological warfare propaganda, (57:34):
undefined

Robert Malone: choose your word, that was deployed to try to suppress the narrative that it (57:38):
undefined

Robert Malone: was MMR that was causing autism, triggered a number of people to think that that was a confirmation, (57:44):
undefined

Robert Malone: that, in fact, it was true because they don't trust the government and they (57:51):
undefined

Robert Malone: don't trust these narratives and this narrative manipulation. (57:54):
undefined

Robert Malone: But this inconvenient fact that in my age cohort and even younger, (57:58):
undefined

Robert Malone: you don't see widespread autism, and yet we all received MMR. (58:04):
undefined

Robert Malone: Well, then maybe the MMR has changed. Oh, what's going on? (58:09):
undefined

Robert Malone: Now, there's no question (58:12):
undefined

Robert Malone: that the mandated pediatric vaccine schedule in the United States has blown (58:16):
undefined

Robert Malone: up since this Ronald Reagan-era set of legislative actions that provided indemnification (58:21):
undefined

Robert Malone: to vaccine manufacturers. (58:33):
undefined

Robert Malone: And in particular, if you could get your vaccine on the pediatric schedule, (58:36):
undefined

Robert Malone: then you got the kind of the full metal jacket of protection from the government. (58:40):
undefined

Robert Malone: And so if you're a vaccine manufacturer, golden calf, you know, (58:45):
undefined

Robert Malone: the hitting striking gold is to get your vaccine product on the schedule. (58:51):
undefined

Robert Malone: And once you have that, for the reasons that I was discussing earlier, (58:58):
undefined

Robert Malone: you have a legacy product that will give you profit ad infinitum that the government buys. (59:03):
undefined

Robert Malone: So you have basically a very easy marketing strategy. (59:11):
undefined

Robert Malone: Um once cdc aci the (59:19):
undefined

Robert Malone: advisory committee on immunization practices endorses your (59:22):
undefined

Robert Malone: product and the director of the cdc says (59:25):
undefined

Robert Malone: yes it automatically gets bought for the vaccines for children program so you (59:29):
undefined

Robert Malone: get an automatic purchase of a very large amount of your product total indemnification (59:35):
undefined

Robert Malone: and because of the other dynamics i was discussing it's in perpetuity Uh, (59:40):
undefined

Robert Malone: you, you have, you know, your shareholders are very happy when you get to that point. (59:47):
undefined

Robert Malone: Uh, and so there's all these incentives to hide problems, to not disclose the (59:53):
undefined

Robert Malone: full breadth of information, to not ask questions that might lead to answers that are inconvenient. (01:00:00):
undefined

Robert Malone: Uh, and then even post-marketing to suppress any discussion about risks associated (01:00:06):
undefined

Robert Malone: with this because all vaccines are safe and effective because that is the official (01:00:13):
undefined

Robert Malone: public policy position. (01:00:17):
undefined

Robert Malone: And so then you get this backlash from the public saying, whoa, (01:00:20):
undefined

Robert Malone: whoa, whoa, whoa, whoa, whoa, whoa. (01:00:25):
undefined

Robert Malone: I, you know, I, Mary over there has got a vaccine injured child and it may be, time will tell, (01:00:26):
undefined

Robert Malone: that this expanded vaccine program where they're jabbing these little kids with all kinds of stuff, (01:00:34):
undefined

Robert Malone: really rapid fire, causes something, and that something may be central nervous system inflammation. (01:00:41):
undefined

Robert Malone: And when you're overloading them with all these large amounts of immunogenic (01:00:52):
undefined

Robert Malone: products that have typically an adjuvant, that's vaccine industry speak, (01:00:58):
undefined

Robert Malone: for something that causes the inflammation to be even more, (01:01:05):
undefined

Robert Malone: to recruit the immune system to respond to whatever the thing is, (01:01:09):
undefined

Robert Malone: it's not the adjuvant, it is the antigen. (01:01:14):
undefined

Robert Malone: Um, that combination of, of hitting kids with all these things in a very rapid (01:01:16):
undefined

Robert Malone: fire, multiple vaccines on the same day, et cetera, (01:01:22):
undefined

Robert Malone: in a subset of children triggers an inflammatory response that may include central (01:01:26):
undefined

Robert Malone: nervous system, inflammation, brain swelling, and that results in the compromise of, uh, (01:01:32):
undefined

Robert Malone: their neurologic integrity and they develop these symptoms. (01:01:40):
undefined

Robert Malone: So the MMR made, because it is administered now together with all this other (01:01:45):
undefined

Robert Malone: stuff, may be triggering that. (01:01:51):
undefined

Robert Malone: But the truth is, the honest truth, is that here in the United States, (01:01:53):
undefined

Robert Malone: we're now exposed to a whole lot of things, (01:01:59):
undefined

Robert Malone: other toxins, that also trigger neuroinflammation that are also shown in animal models to trigger, um, (01:02:02):
undefined

Robert Malone: autistic like, uh, (01:02:12):
undefined

Robert Malone: phenotypes, uh, um, uh, processes. (01:02:15):
undefined

Robert Malone: One of which, for instance, is glyphosate, otherwise known as Roundup, (01:02:19):
undefined

Robert Malone: which is content, you know, virtually all North Americans now, um, (01:02:23):
undefined

Robert Malone: and notoriously North American pregnant women have glyphosate in their urine. (01:02:29):
undefined

Robert Malone: At levels that correspond to levels in rodent studies, if rodents are a predictor. (01:02:35):
undefined

Robert Malone: In gestating rats and mice, (01:02:43):
undefined

Robert Malone: pregnant female rats and mice, (01:02:47):
undefined

Robert Malone: in pups from their offspring that have autistic-like symptoms and obesity. (01:02:50):
undefined

Robert Malone: So glyphosate may be one of the bad actors. Who knows what other bad actors are out there? (01:03:01):
undefined

Robert Malone: And is it all vaccines? Or is this a multifactorial event? (01:03:08):
undefined

Robert Malone: That's going to be really hard. That's a big data question. (01:03:14):
undefined

Hearts of Oak: Which is what Matt has about, actually looking at those range of factors, (01:03:18):
undefined

Hearts of Oak: not only farming but the food and hopefully look at medical insurance as well, (01:03:22):
undefined

Robert Malone: Which is another part of it. We have some cool new tech that is good for analyzing (01:03:27):
undefined

Robert Malone: multifactorial cause and effect. (01:03:33):
undefined

Robert Malone: And the short term for that is artificial intelligence. Mm-hmm. (01:03:37):
undefined

Robert Malone: So it's the same kind of, so that, you know, Doge and Elon Musk and all of those (01:03:45):
undefined

Robert Malone: new IT tech young men, largely, (01:03:54):
undefined

Robert Malone: folks that have been inserted into the government are proving it appears to (01:04:00):
undefined

Robert Malone: be useful, not just in ferreting out corruption and financial malfeasance. (01:04:08):
undefined

Robert Malone: But also potentially in analyzing these public health data. (01:04:15):
undefined

Robert Malone: But in order to do that, they have to get access to these big databases, (01:04:21):
undefined

Robert Malone: and that loops us back around. (01:04:26):
undefined

Hearts of Oak: Yeah, well, we'll see. I hope that whenever those PACs are given out to journalists (01:04:28):
undefined

Hearts of Oak: on autism and vaccine safety, there's more in them than the Kennedy assassination, (01:04:33):
undefined

Hearts of Oak: but that's a whole other area. (01:04:38):
undefined

Hearts of Oak: Robert, I really appreciate your time. There's so much happening, (01:04:41):
undefined

Hearts of Oak: and I love having a guest on that just fits into current events and isn't just around a certain topic. (01:04:45):
undefined

Hearts of Oak: So thank you for giving us your input on all this conversation on measles. (01:04:51):
undefined

Hearts of Oak: It fits into the term Cywar, which, of course, is your latest book. (01:04:56):
undefined

Hearts of Oak: And people want to delve into the role of media in pushing a narrative and agenda. (01:05:02):
undefined

Hearts of Oak: Your book is an excellent place to go, and we'll put the link in the description. (01:05:07):
undefined

Hearts of Oak: And they can get a hold of that copy wherever (01:05:12):
undefined